Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1
about
Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological ActivitiesCombined antiviral activity of interferon-α and RNA interference directed against hepatitis C without affecting vector delivery and gene silencingRetroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectivesHemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectorsProgress and prospects: immune responses to viral vectorsAutophagy interplays with apoptosis and cell cycle regulation in the growth inhibiting effect of Trisenox in HEP-2, a laryngeal squamous cancer.In vivo bioimaging with tissue-specific transcription factor activated luciferase reporters.Inducible nitric oxide synthase mediates DNA double strand breaks in Human T-Cell Leukemia Virus Type 1-induced leukemia/lymphoma.Cellular Redox Status Regulates Emodin-Induced Radiosensitization of Nasopharyngeal Carcinoma Cells In Vitro and In Vivo.Development of the Nanobody display technology to target lentiviral vectors to antigen-presenting cells.Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer.Treatment of adult T-cell leukemia/lymphoma: past, present, and future.HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.Antineoplastic effects of n-3 polyunsaturated fatty acids in combination with drugs and radiotherapy: preventive and therapeutic strategies.The miR-126-VEGFR2 axis controls the innate response to pathogen-associated nucleic acids.Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases.Progress and prospects: prospects of repeated pulmonary administration of viral vectors.Emerging applications of lentiviral vectors in dendritic cell-based immunotherapy.Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects.Hydrogels for lentiviral gene delivery.Restriction of HIV-1-based lentiviral vectors in adult primary marrow-derived and peripheral mobilized human CD34+ hematopoietic stem and progenitor cells occurs prior to viral DNA integration.Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy.An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins.How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery.Effects of arsenic sulfide (As2S2) on B and T lymphoma cell lines and possible underlying mechanisms.HOX-GFP and WOX-GFP lentivirus vectors for inner ear gene transfer.Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: a systematic review.Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.Lentiviral-mediated gene transfer – a patent review
P2860
Q26749631-A9376790-270E-4E29-84C2-53E4AD5DAECBQ27488834-ABC89553-E92D-4FCA-97DC-3A25ABD4FC6AQ28074002-574516BB-B999-4510-9DD0-3AD5EAA86FA2Q28079890-4365387E-DFB6-46CB-BA1A-F26E8639FB83Q28264531-871999D4-E573-4472-BAC8-0F4CBEA65D5FQ35170531-C16C84A6-426F-46AC-98BA-B7DD86AD0F64Q35813391-9F76F138-B2AB-48C7-8DEA-B2B5BEC8C242Q35945853-F986306A-1DB8-4B0B-BB18-C800AA6E8D5EQ36112224-ED7CE02C-C712-4A03-94FF-E5A524817EB3Q36460535-CE20E456-72D3-4E00-BCF5-8E47785BA87FQ36660711-F5DF5668-38B9-4B56-828C-7905EFB4DCA8Q37032793-507C0DB9-9A18-4004-8C69-5567DE197233Q37079191-06A9835B-619A-4274-A3BF-0F8BC5A0F0BCQ37123441-E43B3AD0-1051-4FBD-9560-234D0356518AQ37237164-48F109C7-D3CE-48E7-B63B-A9986029289FQ37424081-DFB07A85-3E8F-44C2-8F10-70B121422A1CQ37448363-04D7E735-4C70-4A91-9318-9438ED95564AQ37495470-B36B5E90-707E-4E2C-9CB2-6D46A6EB21E0Q37522460-C25D8736-71CC-4819-9D05-263D2D236FECQ37566254-B2692B29-C7C9-4AEA-B012-64317C6BAB2BQ37793233-AB0AC34C-055A-4A43-B166-FFAAC3FFC6A0Q37950943-70B0C5E4-CA84-444F-B088-A52F52D48554Q38076509-B2B0CF80-8D02-4792-9F73-BF012E0AEC83Q38797204-6D9707A5-924D-4CAA-A124-E2F1EE01D835Q39134511-CFB33FD4-5448-474F-A4F3-E35F3CA92385Q39148424-1E9138E0-D8E6-461C-9520-EDBD5EB107BAQ39771420-CC773FC7-2F27-4CF4-ABF2-3CCD1F163794Q40187007-0EECF633-77A6-49EC-9DA6-D8DAC1663A7AQ41928769-F9BA1458-8E47-4486-B986-03DAC596A37DQ50630799-145A0853-03B4-4556-84A3-AEB862B432EBQ52726199-B6F154DA-7303-4043-A713-60E9518F69D5Q53702218-592FA962-B8B5-453C-BBBE-357F47DCFD48Q56787021-845FD527-4528-43F3-9343-B89B18F4AAD8
P2860
Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@ast
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@en
type
label
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@ast
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@en
prefLabel
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@ast
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@en
P2093
P2860
P1433
P1476
Emodin and DHA potently increa ...... and inhibition of Akt and AP-1
@en
P2093
Christophe Nicot
Marcia Bellon
Megan Brown
P2860
P304
P356
10.1182/BLOOD-2006-04-015537
P407
P577
2006-10-31T00:00:00Z